Research News for 2010
-
Society Releases New Guidelines on Hormone Replacement Therapy
The North American Menopause Society has developed new guidelines for using hormone replacement therapy that recommend a bone mineral density test after stopping long-term HRT.
-
Zometa with Chemo Before Surgery Helps Kill Breast Cancer Cells in Bone Marrow
Research suggests that adding Zometa to chemotherapy given before early-stage breast cancer surgery may destroy breast cancer cells that have traveled to the bone marrow in some women.
-
Exposure to Certain Chemicals at Young Age Linked to Increase in Risk
A new study links exposure to certain chemicals before age 36 and a higher risk of breast cancer after menopause.
-
Breast Exam Form Improves Referral Rate
Using specific forms to record the results of clinical breast exams may improve the chances of finding suspicious areas.
-
Women Who Would Benefit May Not be Getting Radiation After Mastectomy
While most women don't get radiation after mastectomy, new research suggests that some women may benefit from it.
-
Breast Cancer Cells with High Levels of PARP Enzyme More Likely to Respond to Chemo
Research suggests that cancers with high levels of the PARP enzyme are more likely to respond to chemotherapy.
-
Beta-Blocker Seems to Reduce Risk of Metastatic Spread
New research suggests that beta-blockers may improve breast cancer prognosis.
-
Research on Treatment Options for Diagnosed Women with Abnormal Breast Cancer Genes
A new study found that women with an abnormal breast cancer gene had the same survival rates whether they had mastectomy or lumpectomy plus radiation. Still, women who had lumpectomy plus radiation were between 4 and 5 times more likely to develop another breast cancer in the same breast compared to women who had mastectomy, unless lumpectomy plus radiation was followed by chemotherapy.
-
New Treatment Standard Offered for Metastatic HER2-Positive Disease
A new study suggests that the combination of Navelbine and Herceptin may be better than Taxotere and Herceptin as the first treatment for HER2-positive, metastatic breast cancer.
-
If Breast Cancer Develops, Breastfeeding Longer Seems Linked to More Aggressive Forms
A study suggests an association between breastfeeding for more than 6 months and the likelihood of more aggressive breast cancer, if breast cancer is diagnosed.
